Abstract
Probiotic is a preparation containing microorganisms that confers beneficial effect to the host. This work assessed whether oral treatment with viable or heat-killed yeast Saccharomyces cerevisiae strain UFMG 905 prevents bacterial translocation (BT), intestinal barrier integrity, and stimulates the immunity, in a murine intestinal obstruction (IO) model. Four groups of mice were used: mice undergoing only laparotomy (CTL), undergoing intestinal obstruction (IO) and undergoing intestinal obstruction after previous treatment with viable or heat-killed yeast. BT, determined as uptake of 99mTc-E. coli in blood, mesenteric lymph nodes, liver, spleen and lungs, was significantly higher in IO group than in CTL group. Treatments with both yeasts reduced BT in blood and all organs investigated. The treatment with both yeasts also reduced intestinal permeability as determined by blood uptake of 99mTc-DTPA. Immunological data demonstrated that both treatments were able to significantly increase IL-10 levels, but only viable yeast had the same effect on sIgA levels. Intestinal lesions were more severe in IO group when compared to CTL and yeasts groups. Concluding, both viable and heat-killed cells of yeast prevent BT, probably by immunomodulation and by maintaining gut barrier integrity. Only the stimulation of IgA production seems to depend on the yeast viability.
Similar content being viewed by others
References
Akin ML, Uluutku H, Erenglu C, Ilicak EN, Elbuken E, Erdemoglu A, Celenk T (2002) Hyperbaric oxygen ameliorates bacterial translocation in rats with mechanical intestinal obstruction. Dis Colon Rectum 45:967–972
Aldemir M, Kökoglu OF, Geyik MF, Büyükbayram H (2002) Effects of octreotideacetate and Saccharomyces boulardii on bacterial translocation in an experimental intestinal loop obstruction model of rats. Tohoku J Exp Med 198:1–9
Buts JP, de Keyser N (2006) Effects of Saccharomyces boulardii on intestinal mucosa. Dig Dis Sci 51:1485–1492
Chang TMC, Lu RH, Tsai LM (2001) Glutamine ameliorates mechanical obstruction-induced intestinal injury. J Surg Res 95:133–140
Ciriello CJ, Lachance MA (2001) YEASTCOMPARE. University of Western Ontario, London
Czerucka D, Rampal P (2002) Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes Infect 4:733–739
Dalmasso D, Loubat A, Dahan S, Calle G, Rampal P, Czerucka D (2006) Saccharomyces boulardii prevents TNF-α induced apoptosis in EHEC-infected T84 cells. Res Microbiol 55:1–10
Deitch EA (2002) Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings? Surgery 131:241–244
Diniz ASOF, Resende BM, Nunan EA, Simal CJR, Cardoso VN (1999) 99mTechnetium labelled Escherichia coli. Appl Rad Isot 51:33–36
FAO/WHO Report (2002) Food and Agricultural Organization/World Health Organization Working Group. Guidelines for the evaluation of probiotics in food, London, Ontario, Canada, April 30 and May 1
Fietto JLR, Araújo RS, Valadão FN, Fietto LG, Brandão RL, Neves MJ, Gomes CO, Nicoli JR, Castro IM (2004) Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Can J Microbiol 50:615–621
Gatt M, Reddy BS, Macfie J (2007) Review article: bacterial translocation in the critically ill evidence and methods of prevention. Aliment Pharmacol 25:741–757
Gedek BR (1999) Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 42:261–264
Geyik MF, Aldemir M, Hosoglu S, Ayaz C, Satilmis S, Buyukbayram H, Kokoglu OF (2006) The effects of Saccharomyces boulardii on bacterial translocation in rats with obstruction jaundice. Ann Rev Coll Surg Engl 88:178–180
Grimbaldeston M, Nakae S, Kalesnikoff J, Tsai M, Galli SJ (2007) Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 8:1095–1104
Hajishengallis G, Nikolova E, Russel MW (1992) Inhibition of Streptococcus mutans adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A antibodies to the cell surface protein antigen I/II: reversal by IgA 1 protease cleavage. Infect Immun 60:5057–5064
Herek O, Kara IG, Kaleli I (2004) Effects of antibiotics and Saccharomyces boulardii on bacterial translocation in burn injury. Surg Today 34:256–260
Imaoka A, Shima T, Kato K, Mizuno S, Uehara T, Matsumoto S, Hara ST, Umesaki Y (2008) Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J Gastroenterol 16:2511–2516
Jorgensen B, Keller A, Radvanska E, Rittig S, Taagehoj-Jensen F, Frokiaer J, Jorgensen T, Pedersen M (2006) Reproducibility of contrast enhanced magnetic resonance renography in adolescents. J Urol 176:1171–1176
Kataria J, Li N, Wynn JL, Neu J (2009) Probiotic microbes: do they need to be alive to be beneficial? Nutr Rev 67:546–550
Kumura H, Tanoue Y, Tsukahara M, Tanaka T, Shimazaki K (2004) Screening of dairy yeast strains for probiotic applications. J Dairy Sci 87:4050–4056
Li N, Russell WM, Douglas-Escobar M, Hauser N, Lopez M, Neu J (2009) Live and heat-killed Lactobacillus rhamnosus GG: effects on pro-inflammatory and anti-inflammatory cytokines/chemokines in gastrostomy-fed infant rats. Pediatr Res 66:203–207
Lichtman SM (2001) Bacterial translocation in humans. J Pediatr Gastroenterol Nutr 33:1–10
Martins FS, Nardi RMD, Arantes RME, Rosa CA, Neves MJ, Nicoli JR (2005) Screening of yeast as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice. J Gen Appl Microbiol 51:83–92
Martins FS, Rodrigues ACP, Tiago FCP, Penna FJ, Rosa CA, Arantes RME, Nardi RMD, Neves MJ, Nicoli JR (2007) Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice. J Med Microbiol 56:352–359
Martins FS, Silva AA, Vieira AT, Barbosa FHF, Arantes RME, Teixeira MM, Nicoli JR (2009) Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Arch Microbiol 191:623–630
Miyauchi E, Morita H, Tanabe S (2009) Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo. J Dairy Sci 92:2400–2408
National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington
Oliveira MA, Lemos DL, Diniz ASOF, Coelho J, Cardoso VN (2006) Prevention of bacterial translocation using glutamine: a new strategy of investigation. Nutrition 22:419–424
Quirino IEP, Correia MITD, Cardoso VN (2007) The impact of arginine on bacterial translocation in an intestinal obstruction model in rats. Clin Nutr 26:335–340
Sun Z, Wang X, Deng X, Lasson A, Wallén R, Hallberg E, Andersson R (1998) The influence of intestinal ischemia and reperfusion on bidirectional intestinal barrier permeability, cellular membrane integrity, proteinase inhibitors, and cell death in rats. Shock 10:203–212
Surawicz CM (2003) Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Pract Res Clin Gastroenterol 17:775–783
Tannock G (2005) Probiotics and prebiotics: scientific aspects, 1st edn. Caister Academic Press, University of Otago, Dunedin
Tiago FCP, Martins FS, Rosa CA, Nardi RMD, Cara DC, Nicoli JR (2009) Physiological characterization of non-Saccharomyces yeasts from agro-industrial and environmental origins with possible probiotic function. World J Microbiol Biotechnol 25:657–666
Viana M, Santos R, Generoso S, Arantes R, Correia M, Cardoso V (2009) Pretreatment with arginine preserves intestinal barrier integrity and reduces bacterial translocation in mice. Nutrition 26:218–233
Wiest R, Rath HC (2003) Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol 17:397–425
Acknowledgments
The study was supported by grants from Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) and Conselho Nacional de Pesquisa (CNPq). The authors thank Dr. Carlos A. Rosa for providing the yeast S. cerevisiae 905.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Erko Stackebrandt.
Rights and permissions
About this article
Cite this article
Generoso, S.V., Viana, M., Santos, R. et al. Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model. Arch Microbiol 192, 477–484 (2010). https://doi.org/10.1007/s00203-010-0574-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00203-010-0574-8